VITASTEMVitaStem
$0.0307
$0.0012
(4.16%)
Mkt Cap$98,103.00
Vol276.77
<
...
1
>
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
AboutVitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.
DetailsCategories
Base EcosystemClanker EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
June 25, 2026
$98,102.78
$276.77
---
June 25, 2026
$94,443.51
$238.47
---
June 24, 2026
$98,145.73
$176.82
$0.0308
June 23, 2026
$97,951.66
$425.62
$0.0307
June 22, 2026
$102,206.18
$101.33
$0.032
June 21, 2026
$106,280.16
$217.17
$0.0333
June 20, 2026
$112,894.20
$250.06
$0.0354
June 19, 2026
$119,062.36
$787.89
$0.0373
June 18, 2026
$112,652.74
$910.80
$0.0353
June 17, 2026
$101,114.74
$53.36
$0.0317